Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Hendricks

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Neuropharmacology|August 20, 2022
Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act schedulingJack E Henningfield, Marion A Coe, Roland R Griffiths, et al.
Tobacco Induced Diseases|September 25, 2023
The relationship between chronic lung disease diagnosis and the susceptibility to e-cigarette use in adults: The mediation effects of psychosocial, cognitive influences, and the moderation effect of physiological factorsMohammed M Alqahtani, Abdullah M M Alanazi, Hassan Aljohani, et al.
Psychiatric Research and Clinical Practice|April 2, 2025
On Minimizing Risk and Harm in the Use of PsychedelicsJules Evans, Marc Aixalà, Brian T Anderson, et al.
JAMA Psychiatry|November 30, 2022
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A ReviewBrian D Kiluk, Bethea A Kleykamp, Sandra D Comer, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|May 12, 2025
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of ResearchDavid B Yaden, Marianna Graziosi, Alexa M Owen, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Neuropharmacology|August 20, 2022
Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act schedulingJack E Henningfield, Marion A Coe, Roland R Griffiths, et al.
Tobacco Induced Diseases|September 25, 2023
The relationship between chronic lung disease diagnosis and the susceptibility to e-cigarette use in adults: The mediation effects of psychosocial, cognitive influences, and the moderation effect of physiological factorsMohammed M Alqahtani, Abdullah M M Alanazi, Hassan Aljohani, et al.
Psychiatric Research and Clinical Practice|April 2, 2025
On Minimizing Risk and Harm in the Use of PsychedelicsJules Evans, Marc Aixalà, Brian T Anderson, et al.
JAMA Psychiatry|November 30, 2022
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A ReviewBrian D Kiluk, Bethea A Kleykamp, Sandra D Comer, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|May 12, 2025
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of ResearchDavid B Yaden, Marianna Graziosi, Alexa M Owen, et al.
Pageof 15